Toxicities of amoxapine

Mapping of validated apathy scales onto the apathy diagnostic criteria for neurocognitive disorders.

International psychogeriatrics·2025

Validation of a suite of ERP and QEEG biomarkers in a pre-competitive, industry-led study in subjects with schizophrenia and healthy volunteers.

Schizophrenia research·2023

A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients.

Molecular psychiatry·2015

Peripheral and central nervous system inhibition of 11β-hydroxysteroid dehydrogenase type 1 in man by the novel inhibitor ABT-384.

Translational psychiatry·2013

Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.

Antimicrobial agents and chemotherapy·2008

Pharmacokinetics and pharmacodynamics of the novel daily rivastigmine transdermal patch compared with twice-daily capsules in Alzheimer's disease patients.

Clinical pharmacology and therapeutics·2007

Efficacy of nutritional supplements used by athletes.

Clinical pharmacy·1993

Low-molecular-weight heparins for the treatment of deep-vein thrombosis.

Clinical pharmacy·1993

Sotalol: a new class III antiarrhythmic agent.

Clinical pharmacy·1993

Zolpidem: a nonbenzodiazepine hypnotic for treatment of insomnia.

Clinical pharmacy·1993

Pathophysiology of septic shock and implications for therapy.

Clinical pharmacy·1993

Cladribine for the treatment of hematologic malignancies.

Clinical pharmacy·1993

In-life Chemical Inactivation of Plasmodium Parasites by Cabamiquine Induces Long Lasting Immune Protection.

The Journal of infectious diseases·2026

Dexpramipexole alleviates chronic allodynia from sciatic neuropathy and reduces spinal interferon-γ and other proinflammatory cytokines in spinal cord and dorsal root ganglia in mice.

Medical research archives·2026

Corrigendum to "Mobile intervention for emerging adults with regular cannabis use: a micro-randomized trial" [The Lancet Regional Health-Americas 2026; Volume 61: 101524; DOI: 10.1016/j.lana.2026.101524].

Lancet regional health. Americas·2026

Cannabis-Based Medicinal Products for Endometriosis: A 2-Year Prospective Analysis From the UK Medical Cannabis Registry.

The Australian & New Zealand journal of obstetrics & gynaecology·2026

Hydrogel-forming Microneedles for Multi-drug and Phytochemical Co-delivery: Translational Opportunities in Autoimmune and Inflammatory Disorders.

Reviews on recent clinical trials·2026

Long-term experiences of patients prescribed medicinal cannabis in Australia: a qualitative interview study.

Australian journal of primary health·2026

Related Experiment Videos

Toxicities of amoxapine

Related Concept Videos

Mapping of validated apathy scales onto the apathy diagnostic criteria for neurocognitive disorders.

Validation of a suite of ERP and QEEG biomarkers in a pre-competitive, industry-led study in subjects with schizophrenia and healthy volunteers.

A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients.

Peripheral and central nervous system inhibition of 11β-hydroxysteroid dehydrogenase type 1 in man by the novel inhibitor ABT-384.

Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.

Pharmacokinetics and pharmacodynamics of the novel daily rivastigmine transdermal patch compared with twice-daily capsules in Alzheimer's disease patients.

Efficacy of nutritional supplements used by athletes.

Low-molecular-weight heparins for the treatment of deep-vein thrombosis.

Sotalol: a new class III antiarrhythmic agent.

Zolpidem: a nonbenzodiazepine hypnotic for treatment of insomnia.

Pathophysiology of septic shock and implications for therapy.

Cladribine for the treatment of hematologic malignancies.

In-life Chemical Inactivation of Plasmodium Parasites by Cabamiquine Induces Long Lasting Immune Protection.

Dexpramipexole alleviates chronic allodynia from sciatic neuropathy and reduces spinal interferon-γ and other proinflammatory cytokines in spinal cord and dorsal root ganglia in mice.

Corrigendum to "Mobile intervention for emerging adults with regular cannabis use: a micro-randomized trial" [The Lancet Regional Health-Americas 2026; Volume 61: 101524; DOI: 10.1016/j.lana.2026.101524].

Cannabis-Based Medicinal Products for Endometriosis: A 2-Year Prospective Analysis From the UK Medical Cannabis Registry.

Hydrogel-forming Microneedles for Multi-drug and Phytochemical Co-delivery: Translational Opportunities in Autoimmune and Inflammatory Disorders.

Long-term experiences of patients prescribed medicinal cannabis in Australia: a qualitative interview study.

Related Experiment Videos

Toxicities of amoxapine

Related Concept Videos

Related Articles